ELV

Elevance Health
D

ELV

Arincen57/100B

Elevance Health cash flow statement 2001–2026

Elevance Health's free cash flow over the last twelve months was 6.51B USD: operating cash flow of 7.60B USD less 1.08B USD of capital spending. That is 3.2% of its revenue and 29.69 a share.

Operating cash flow Free cash flow

Click a line's chart icon in the table to add it to the chart; hover over it for a quick look.

Fiscal year
TTM
30 Sept 2026
FY2025
31 Dec 2025
FY2024
31 Dec 2024
FY2023
31 Dec 2023
FY2022
31 Dec 2022
FY2021
31 Dec 2021
FY2020
31 Dec 2020
FY2019
31 Dec 2019
FY2018
31 Dec 2018
FY2017
31 Dec 2017
FY2016
31 Dec 2016
Net income
5.10B5.66B5.97B5.99B6.02B6.10B4.57B4.81B3.75B3.84B2.47B
Depreciation and amortization
1.49B1.55B1.39B1.75B1.68B1.30B1.15B1.13B1.13B891.00M912.00M
Stock-based compensation
240.00M276.00M191.00M289.00M264.00M255.00M283.00M294.00M226.00M169.60M164.60M
Change in working capital
654.00M-3.28B-1.72B-535.00M253.00M784.00M5.20B-192.00M-1.60B367.90M-574.90M
Change in receivables
-140.00M-2.53B-683.00M-1.76B-2.51B-2.14B-256.00M-1.05B-707.00M-22.20M-1.38B
Change in inventory
—0.000.000.002.51B2.14B256.00M593.00M-1.10B-53.10M780.30M
Change in payables
-1.02B-720.00M-272.00M1.64B252.00M719.00M1.98B-593.00M122.00M921.80M116.60M
Change in other working capital
1.81B-31.00M-764.00M-413.00M1.00M65.00M3.23B861.00M82.00M-478.60M-91.30M
Other non-cash items
575.00M363.00M346.00M1.18B264.00M-245.00M16.00M-62.00M230.00M185.60M106.10M
Operating cash flow
7.60B4.29B5.81B8.06B8.40B8.36B10.69B6.06B3.83B4.18B3.20B
Operating cash flow growth
+54.64%-26.14%-27.95%-4.02%+0.42%-21.74%+76.34%+58.37%-8.55%+30.59%-22.15%
Capital expenditure
-1.08B-1.12B-1.26B-1.30B-1.15B-1.09B-1.02B-1.08B-1.21B-790.20M-583.60M
Acquisitions
—88.00M-4.45B-1.55B-649.00M-3.48B-1.98B0.00-1.76B-2.08B0.00
Purchases of investments
-8.84B-15.03B-17.99B-16.24B-24.95B-18.67B-19.49B-22.95B-9.67B-16.37B-12.10B
Sales and maturities of investments
7.83B15.10B18.57B13.54B22.61B14.61B16.06B21.04B11.60B13.53B11.95B
Other investing
-950.00M-385.00M-51.00M-24.00M-421.00M-1.02B-894.00M204.00M-220.00M636.40M219.00M
Investing cash flow
-3.01B-1.34B-5.17B-5.57B-4.56B-9.64B-7.32B-2.79B-1.26B-5.08B-513.90M
Debt issued (repaid)
—2.33B5.56B739.00M1.80B2.34B188.00M608.00M-849.00M3.72B360.00M
Shares issued
83.00M0.000.000.000.000.000.000.001.25B0.000.00
Share buybacks
-2.16B-2.61B-2.90B-2.68B-2.32B-1.90B-2.70B-1.70B-1.69B-2.00B-67.00M
Dividends paid
-1.50B-1.53B-1.51B-1.40B-1.23B-1.10B-954.00M-818.00M-776.00M-704.90M-684.00M
Other financing
225.00M69.00M39.00M-17.00M432.00M1.08B899.00M-271.00M-355.00M-820.70M-408.90M
Financing cash flow
-2.94B-1.74B1.19B-3.35B-1.32B423.00M-2.57B-2.27B-2.24B426.90M-732.90M
Net change in cash
1.64B1.20B1.76B-861.00M2.51B-861.00M804.00M1.00B325.00M-466.40M1.96B
Free cash flow
6.51B3.17B4.55B6.77B7.25B7.28B9.67B4.98B2.62B3.39B2.62B
Free cash flow growth
+72.92%-30.27%-32.71%-6.65%-0.41%-24.72%+93.96%+90.30%-22.85%+29.52%-25.40%
Free cash flow margin
3.23%1.59%2.57%3.95%4.63%5.25%7.93%4.78%2.84%3.77%3.08%
Free cash flow per share
29.6914.3119.5428.5029.8529.4938.0119.1510.3012.689.78
Free cash flow per share growth
+79.27%-26.78%-31.41%-4.53%+1.23%-22.44%+98.54%+85.92%-18.75%+29.67%-24.06%
Owner earnings (estimate)
6.73B3.85B4.72B7.22B7.80B7.78B10.18B5.32B2.67B3.52B2.76B
Income taxes paid
—0.000.000.000.000.000.000.000.000.000.00

Figures in USD. Free cash flow is operating cash flow less capital expenditure; owner earnings take off only the spending that keeps the business as it is, not the spending to grow it (an estimate by Financial Modeling Prep). Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

Common questions about Elevance Health's cash flow

Source: Financial Modeling Prep